Angion Announces Participation in Upcoming Investment Conference
UNIONDALE, N.Y., May 12, 2022 (GLOBE NEWSWIRE) -- Angion Biomedica Corp. (NASDAQ:ANGN), a biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to address fibrotic diseases, today announced participation in an upcoming investment conference.
Angion’s President and CEO, Dr. Jay Venkatesan, will participate virtually in the H.C. Wainwright Global Investment Conference. Details are as follows:
Event: H.C. Wainwright Global Investment Conference
A webcast of the event will be accessible online by visiting the events and presentations page under the investors section of Angion’s website t https://ir.angion.com/events-presentations. The webcast will remain archived on Angion’s website for approximately 30 days.
About Angion Biomedica Corp.
Contact David D. Miller Sr. Director of Communications & Investor Relations [email protected]
Asset Management â€“ Keeping Remote Devices Connected
MDR â€“ A Modern Approach to Data Security and Compliance
Common Mistakes Dispensaries Make Implementing Technology